Staff Data Search - جامعة الزقازيق

Personal Website

Marwa Zakaria Mohammed Mustafa

Faculty Medicine - Department Pediatric Medicine
NULL

Scientific degrees

BSc In , [2004]
MSc In NULL, [2009]
(Thromboembolic Disorders in Childhood Cancer /)
PhD In NULL, [2014]

الحالة الوظيفية الحالية :

قائم بالعمل

Academic Jobs

معيد : 27/7/2009
Doctor Assisant : 31/10/2009
Doctor : 29/4/2014
Professor Assisant : 28/5/2019
Professor : 1/7/2024

Publications

1 - First Report of Acute Lymphoblastic Leukemia in an Egyptian Child with b-Thalassemia Major (2015).

2 - Renal Presentation in Pediatric Acute Leukemia Report of 2 Cases (2015).

3 - Target Therapy in Neuroblastoma (2017).

4 - CHANGE IN IMMUNOLOGICAL MEMORY OF HEPATITIS B VACCINE AFTER CHEMOTHERAPY; A REAL PROBLEM IN PEDIATRIC CANCER PATIENTS (2016).

5 - Evaluation of the Immune Response to Interferon Gamma Release Assay and Tuberculin Skin Test Among BCG Vaccinated Children in East of Egypt A Cross-Sectional Study (2016).

6 - Status of serum magnesium in Egyptian children with type 1 diabetes and its correlation to glycemic control and lipid profile (2016).

7 - Impact of iron deﬁciency anemia on the function of the immune system in children (2016).

8 - Effect of breastfeeding versus infant formula on iron status of infants with beta thalassemia major (2017).

9 - Presepsin as a diagnostic marker of bacterial infections in febrile neutropenic pediatric patients with hematological malignancies (2018).

10 - Impact of genotype of beta globin gene on hepatic and myocardial iron content in Egyptian patients with beta thalassemia (2018).

11 - Association between genotype and disease complications in Egyptian patients with beta thalassemia: A Cross-sectional study (2018).

12 - Chemotherapy‑induced neutropenia among pediatric cancer patients in Egypt: Risks and consequences (2016).

13 - Impact of genotype on endocrinal complications in β‑thalassemia patients (2016).

14 - Cluster of differentiation 97 as a biomarker for the detection of minimal residual disease in common acute lymphoblastic leukemia (2017).

15 - Genetic polymorphism of vitamin D receptors and plasminogen activator inhibitor-1 and osteonecrosis risk in childhood acute lymphoblastic leukemia (2021).

16 - FcgRIIa and FcgRIIIa genes polymorphism in Egyptian children with primary immune thrombocytopenia (2021).

17 - Cerebral sinuses thrombosis prior to the diagnosis of acute lymphoblastic leukemia in a child: A case report (2022).

18 - Assessment of serum aflatoxin B1 levels in neonatal jaundice with glucose 6 phosphate dehydrogenase defciency: a preliminary study (2021).

19 - PTPN22 gene polymorphism as a genetic risk factor for primary immune thrombocytopenia in Egyptian children (2021).

20 - Serum endocan and endothelial dysfunction in childhood acute lymphoblastic leukemia survivors: a tertiary center experience (2021).

21 - Contribution of interleukin 27 serum level to pathogenesis and prognosis in children with immune thrombocytopenia (2022).

22 - Association between ATP binding cassette gene member 1 polymorphism and glucocorticoid response in children with immune thrombocytopenia (2022).

23 - Role of serum cystatin C in the prediction of acute kidney injury following pediatric cardiac surgeries A single center experience (2022).

24 - Role of interleukin 4 (IL4) and interleukin 6 (IL6) in the pathogenesis and prognosis of childhood primary immune thrombocytopenia (2023).

25 - Contribution of T helper 17 cells and interleukin 17 to the pathogenesis of primary immune thrombocytopenia in Egyptian children (2023).

26 - Tissue factor expression predicts outcome in children with neuroblastoma: A retrospective stud (2019).

27 - Subclinical nephrotoxicity in patients with beta-thalassemia: role of urinary kidney injury molecule (2019).

28 - Transfusion of blood components in pediatric age groups: an evidence-based clinical practice guideline adapted for the use in Egypt using ‘Adapted ADAPTE’ (2024).

29 - Diagnosis, management and prevention of Pediatric Acute Hemolytic Anemia: Egyptian adapted evidence-based clinical practice guidelines (2023).

30 - Place of Emicizumab in the Management of Hemophilia A: Review Article (2023).

31 - HEMOCHROMATOSIS HFE GENE POLYMORPHISM AND DEVELOPMENT OF PREDIABETES AND DIABETES MELLITUS IN B THALASSEMIC PATIENTS (2022).

32 - Prevalence of Acute Kidney Injury in Pediatric Patients with Congenital Heart Disease Following Open Heart Surgery (2021).

33 - Association Between BAFF Gene Polymorphism And Clinical course of Newly Diagnosed Immune Thrombocytopenic Purpura In Children (2020).

34 - Efficacy and Safety of Eltrombopag for the Treatment of Chronic Idiopathic Thrombocytopenic Purpura in Children and Adolescents (2019).

35 - Deviation from Guidelines in Use of Eltrombopag and Romiplostim in Clinical Practice for Children with Primary Immune Thrombocytopenia; Multi-Center Egyptian Experience (2019).

36 - Prevalence, Prognosis, and Outcome in Egyptian Children with Primary Immune Thrombocytopenia: A Single-Center Experience (2021).

37 - Vitamin D Status and Risk of Osteoporosis in Hemophilia Patients (2022).

38 - • Ocular radiological findings in Children with Acute Lymphoblastic Leukemia: a cross sectional study (2023).

39 - A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events (2016).

40 - .Can CD34/CD123 distinguish between normal and leukemic B-cell precursors (2017).

Research Area

طب الاطفال